tiprankstipranks
Advertisement
Advertisement

MicroTech Medical Sets 2025 AGM to Approve Results and Expand Capital Mandates

Story Highlights
  • MicroTech Medical will hold its 2025 AGM on June 10, 2026 to approve annual results, governance reports and a profit distribution plan.
  • Shareholders will vote on auditor reappointment and broad mandates for issuing new shares and repurchasing H shares, enhancing capital flexibility.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
MicroTech Medical Sets 2025 AGM to Approve Results and Expand Capital Mandates

Meet Samuel – Your Personal Investing Prophet

The latest update is out from MicroTech Medical (Hangzhou) Co., Ltd. Class H ( (HK:2235) ).

MicroTech Medical (Hangzhou) Co., Ltd. has convened its 2025 annual general meeting for June 10, 2026, in Hangzhou to seek shareholder approval of its 2025 annual report, audited financial statements and key governance reports from the board and supervisory committee. The meeting will also review the final accounts and a proposed profit distribution plan, underscoring the company’s focus on financial transparency and returning value to investors.

Shareholders will be asked to reappoint the auditor for 2026 and grant the board authority to set the auditor’s remuneration, while also voting on mandates to issue up to 20% additional shares and repurchase up to 10% of H shares. These proposed mandates, together with detailed proxy and voting arrangements, are designed to give MicroTech Medical greater capital management flexibility and enhance its ability to respond to market conditions and support long‑term shareholder interests.

The most recent analyst rating on (HK:2235) stock is a Hold with a HK$8.90 price target. To see the full list of analyst forecasts on MicroTech Medical (Hangzhou) Co., Ltd. Class H stock, see the HK:2235 Stock Forecast page.

More about MicroTech Medical (Hangzhou) Co., Ltd. Class H

MicroTech Medical (Hangzhou) Co., Ltd. is a medical technology company based in Hangzhou, Zhejiang Province, China, and its H shares are listed in Hong Kong under stock code 2235. The company operates in the healthcare sector, focusing on medical devices and related technologies, and maintains both H share and unlisted share registers for its diverse shareholder base.

Average Trading Volume: 142,815

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$3.35B

For detailed information about 2235 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1